Poland· PL-100435396

Crealb 40 g/l

A albumin product containing albumini humani solutio, registered in Poland by Prothya Biosolutions Netherlands B.V.. The same ATC class is registered in 13 of our 19 countries.

ATC B05AA01

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedCrealb 40 g/lATCB05AA01REGISTER NO.PL-100435396PACKS LISTED1CHECKEDSeptember 27, 2026

Where it is registered

Albumin is registered in 13 of 19 countries.

Countries holding a registration under ATC B05AA01 (albumin), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 8 of them publish a price we can compare per daily dose

Albumin · ATC B05AA01

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Albumini humani solutio
Manufacturer
Prothya Biosolutions Netherlands B.V.
Country
Poland (PL)
ATC code
B05AA01
ATC class
Albumin
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    08717185835076

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Albumin in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All albumin products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Albiomin, Albunorm
  • Belgium · Albunorm, Human Albumin Baxalta
  • Bulgaria · Aлбунорм, Албиомин
  • Cyprus · Albiomin, Albuman
  • Czechia · Albunorm, Albutein
  • Germany · Albiomin, Albunorm
  • Denmark · Albumin Baxalta, Albumin Grifols
  • Estonia · Albumin Baxalta, Albunorm
  • Spain · Albiomin, Albuplan
  • Finland · Albuman, Albumin Baxalta
  • France · Albumine Humaine, Albunorm
  • United Kingdom (Northern Ireland) · Albunorm, Albutein
  • Greece · Albiomin, Albumine Lfb
  • Croatia · Albutein, Flexbumin
  • Hungary · Albumon, Albunorm
  • Ireland · Albunorm, Albutein
  • Iceland · Albuman, Albumin Baxalta
  • Italy · Albiomin, Albital
  • Lithuania · Albumin Baxalta, Albunorm
  • Luxembourg · Albunorm, Human Albumin Baxalta
  • Latvia · Albumin Baxalta, Albunorm
  • Malta · Albiomin, Albunorm
  • Netherlands · Albuman, Albunorm
  • Norway · Albumin Baxalta, Albumin Grifols
  • Portugal · Albiomin, Albumina Humana Baxalta
  • Romania · Albiomin, Albumină Umană Baxalta
  • Sweden · Albumin Baxalta, Albumin Octapharma
  • Slovenia · Albunorm, Flexbumin
  • Slovakia · Albunorm, Albutein

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/20050d6b-9455-4b9e-b353-35225e7aab39
GET /v1/drugs/20050d6b-9455-4b9e-b353-35225e7aab39?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Roztwór do infuzji",
  "source": "urpl",
  "strength": "40 g/l",
  "packaging": "08717185835076 ¦ Lz ¦ 139699\n1 fiol. 250 ml",
  "substance": "Albumini humani solutio 40 g/l",
  "common_name": "Albumini humani solutio",
  "pl_product_id": "100435396",
  "pozwolenie_nr": "26304",
  "auth_procedure": "MRP",
  "authorisation_validity": "2023-12-29"
}

See everything about albumin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.